BioSyntagma's Grant

BioSyntagma raised a round of funding on December 08, 2016. Investors include National Science Foundation.

bioSyntagma has developed a device that enables researchers and drug developers to interrogate samples at an unprecedented level, making personalized medicine a more imminent reality.…

Articles about BioSyntagma's Grant: